| Patents for C07J 3 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom (1,033) |
|---|
| 04/28/2005 | US20050090675 Oxidation with hydrogen peroxide in basic environment/polar solvent; crystallization; for producing fluticasone propionate |
| 04/28/2005 | US20050090477 Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-halogen steroids that can be produced therefrom, their process for production and use as well as pharmaceutical prepartions that contain these compounds, as well as 7-substituted estra-1,3,5(10)-trienses that can be produced therefrom |
| 04/27/2005 | EP1526139A1 A process for preparing highly pure androstane 17-beta-carboxylic acids and androstane 17-beta-carbothioic acid fluoromethyl esters |
| 04/20/2005 | EP1523568A2 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 04/19/2005 | US6881728 14-β, 17-α-hydroxymethylandrostane derivatives as androgens |
| 04/07/2005 | WO2005030221A1 Therapeutic agent for ageing macular degeneration |
| 04/07/2005 | WO2005030120A2 Antiangiogenic agents |
| 04/07/2005 | US20050075379 5-(ester-substituted benzyl or benzylidene)-thiazolidine-2,4-diones; readily metabolized by the physiological metabolic drug detoxification systems without loss of therapeutic benefit; lower side effects and toxicity in patients with elevated or compromised liver function |
| 04/07/2005 | US20050075321 Neurological disorder treatment methods |
| 04/07/2005 | CA2537874A1 Therapeutic agent for ageing macular degeneration |
| 04/07/2005 | CA2527074A1 Antiangiogenic agents |
| 04/06/2005 | EP1299409B1 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 04/06/2005 | EP1212618A4 Effect of steroids on nmda receptors depends on subunit composition |
| 03/31/2005 | WO2002042319A9 2-substituted estrogens as antiangiogenic agents |
| 03/31/2005 | US20050070515 Glucocorticosteroids which are hydrolysable in human or animal blood by lactonase enzyme; for treatment of respiratory and gastrointestinal disorders; side effect reduction |
| 03/16/2005 | CN1596241A Method for the preparation of 6alpha-fluoro corticosteroids |
| 03/16/2005 | CN1594349A Process for connecting side chain to androstane compound at 17th position |
| 02/24/2005 | US20050043284 containing an anti-inflammatory and anti-allergic compound of the androstane series |
| 02/22/2005 | US6858596 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler |
| 02/17/2005 | US20050037997 Detoxification; hydrolases or esterases; short half-life; non-insulin dependent diabetes; side effect reduction |
| 02/16/2005 | CN1580071A Looking-glass plant triterpene active placement, and its preparing method and use |
| 02/15/2005 | CA2124339C Novel 19-nor steroids having a thiocarbon-containing chain in the 11 beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositionscontaining said steroids |
| 02/03/2005 | US20050026888 Formulation containing anti-inflammatory androstane derivatives |
| 02/02/2005 | CN1187364C 类固醇衍生物 Steroid derivatives |
| 01/27/2005 | US20050020549 aqueous suspension; rhinitis therapy |
| 01/20/2005 | WO2005005452A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 01/20/2005 | WO2005005451A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 01/20/2005 | US20050014737 Antiangiogenic agents |
| 01/19/2005 | EP1497310A2 A process for the preparation of 6 alfa-fluoro steroids by isomerisation of 6.beta.-fluorosteroids |
| 01/13/2005 | US20050009797 Androstane derivative having substituent in 7- abd 17--positions |
| 11/24/2004 | EP1478340A1 Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions |
| 11/23/2004 | CA2171329C Androstenones |
| 11/11/2004 | US20040225139 a 3-oxo-androstrane carbothioic acid compound |
| 11/11/2004 | US20040224934 3 -oxo-androstrane carbothioic acid compound |
| 11/11/2004 | US20040224932 crystal structure; antiinflammatory agents; antiallergens |
| 11/11/2004 | US20040224931 3-oxo-androstrane carbothioic acid compound |
| 11/09/2004 | CA2170047C Androstenone derivative |
| 11/04/2004 | US20040220162 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 11/04/2004 | US20040220161 using 6-bromo-3-hydroxyandrostan-17-one |
| 11/04/2004 | US20040220159 osteoporosis, periodontal diseases, aging resistance, antilipemic agents, anticholesterol agents, canticancer agents, antiarthritic agents, sexual disorders |
| 11/04/2004 | US20040220157 a 3-oxoandrostrane carbothioic acid compound |
| 11/04/2004 | US20040220114 Pharmaceutical compositions and treatment methods |
| 11/03/2004 | EP1472272A1 Crystalline complexes of fluticasone 2-furoate |
| 11/03/2004 | EP1471900A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions |
| 11/03/2004 | EP1471896A1 Formulations for inhalation |
| 11/03/2004 | EP1471884A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier |
| 11/03/2004 | CN1173702C Glucocorticoid containing pharmaceutical inhalant powder and method for sterilizing the powder |
| 10/14/2004 | WO2004087731A1 Process for the preparation of steroidal carbothioic acid derivatives and intermediates |
| 10/14/2004 | WO2004039827A3 Glucocorticosteroids having a specific 17a-sidechain useful as antiinflammatory agents |
| 10/14/2004 | US20040204490 Contacting with neurotransmitter recognition site ligand in the presence and absence of a steroid-based molecule; chimeric isoform; use in therapy of neurological disorders including ischemic stroke, epilepsy and schizophrenia |
| 10/14/2004 | CA2530680A1 Process for the preparation of steroidal carbothioic acid derivatives and intermediates |
| 10/13/2004 | EP1466920A1 Process for the preparation of steroidal 17 beta-carbothioates |
| 10/13/2004 | EP1465855A2 Method for the production of 6-alpha-fluoro corticosteroids |
| 09/22/2004 | CN1531544A Preparation of fluorine compound and its 17-carboxyl androstene analog |
| 09/14/2004 | CA2254079C Androstene derivatives |
| 09/08/2004 | EP1220867B1 Process to prepare androst-4-en-17-carboxylic acid |
| 09/08/2004 | CN1526722A New taraxerol derivative and its prepn and use |
| 09/07/2004 | US6787532 Formulation containing anti-inflammatory androstane derivatives |
| 08/25/2004 | EP1003553B1 The use of angiostatic steroids in photodynamic therapy |
| 08/19/2004 | US20040162425 6,7-Oxygenated steroids and uses related thereto |
| 08/17/2004 | US6777399 Anti-inflammatory androstane derivative compositions |
| 08/12/2004 | US20040157814 6, 7-Oxygenated steroids and uses related thereto |
| 08/10/2004 | CA2102400C Method for making 3.alpha.-hydroxy, 3.beta.-substituted-pregnanes |
| 08/05/2004 | US20040152681 Interact with nuclear liver X receptor (LXR) and ubiquitous receptor (UR) and can be used to treat a variety of LXR- or UR-mediated disorders |
| 07/27/2004 | US6768008 For therapy |
| 07/15/2004 | WO2004011663A3 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/08/2004 | US20040132700 Use of fluticasone propionate in the treatment of diseases ameliorated by enhancement of epithelial madrix adhesion such as asthma cystic fibrosis and influenza |
| 07/07/2004 | EP1434786A1 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 07/06/2004 | US6759398 Anti-inflammatory androstane derivative |
| 06/23/2004 | EP1430039A2 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis |
| 06/17/2004 | US20040116359 Administering 16 alpha -bromo-3 beta -hydroxy-5 alpha -androstan-17-one hemihydrate and one or more excipients for therapy of pathogen infection, an autoimmune disease, inflammation or allergy, osteoporosis, acute myelitis, sarcoidosis, a cancer |
| 06/16/2004 | EP0977725B1 New fatty acid derivatives |
| 06/15/2004 | US6750210 Formulation containing novel anti-inflammatory androstane derivative |
| 06/08/2004 | US6747163 Oxidization of flumethasone with periodic acid in thf-water, cooling below 10 degrees c., adding water precooled below 10 degrees c., and filtering crystals; good crystalline form, high purity and yield |
| 05/27/2004 | US20040102425 Selective glucocorticoid receptor agonists |
| 05/26/2004 | EP1422234A2 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
| 05/25/2004 | CA2149777C New steroids |
| 05/20/2004 | US20040097406 Pharmaceutical compositions and treatment methods - 4 |
| 05/13/2004 | WO2004039827A2 Glucocorticosteroids having a specific 17a-sidechain useful as antiinflammatory agents |
| 05/06/2004 | WO2004011663A9 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 04/08/2004 | WO2004001369A3 Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate |
| 04/08/2004 | US20040068001 Using hydroxy-3-methylglutaryl/3-/ coenzyme inhibitor |
| 04/07/2004 | CN1144812C Androstene derivative |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 03/16/2004 | US6706701 6, 7-oxygenated steroids and uses related thereto |
| 03/10/2004 | EP1395603A1 Preparation of flumethasone and its 17-carboxyl androsten analogue |
| 03/04/2004 | US20040043974 Antiinflammatory agents; asthma; chronic obstructive pulmonary disease |
| 03/04/2004 | US20040043973 Pharmaceutical compositions and treatment methods |
| 03/04/2004 | US20040043972 Autoimmune disease; antidiabetic agents |
| 03/03/2004 | EP1392320A1 17-METHYLENE-ANDROSTAN-3a-OL ANALOGS AS CRH INHIBITORS |
| 03/03/2004 | EP0998484B1 Method of identifying compounds having reduced systemic effects |
| 02/18/2004 | EP1163256B1 Hemihydrate of 16.alpha.-bromoepiandrosterone |
| 02/18/2004 | EP1032396B1 Sterilization of glucocorticosteroids |
| 02/12/2004 | DE10233723A1 Preparation of 7 alpha-substituted 11 alpha-hydroxy-steroids, useful as precursors for new androgenic 7 alpha,17 alpha-substituted 11 beta-halo-steroids, by microbiological conversion of 7 alpha-substituted steroids |
| 02/05/2004 | WO2004011663A2 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 01/29/2004 | WO2004009527A1 Materials and methods for treating hypercholesterolemia |
| 01/29/2004 | CA2492906A1 Materials and methods for treating hypercholesterolemia |
| 01/27/2004 | CA2115015C Process for the preparation of 6alpha,9alpha-difluorinated steroids and novel intermediates obtained thereby |
| 01/21/2004 | EP0914165A4 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |